Extracellular Vesicles Mir-574-5p and Mir-181A-5p As Prognostic Markers in NSCLC Patients Treated with Nivolumab
CLINICAL AND EXPERIMENTAL MEDICINE（2024）
关键词
Non-small cell lung cancer (NSCLC),Immune checkpoint inhibitor,Nivolumab,Extracellular vesicle miRNA,Prognosis score,miR-574-5p and miR-181a-5p,Pluripotency of stem cell,Toll-like receptor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要